Accelerating the development of new drug development technologies and therapeutics to unlock ground-breaking biopharmaceuticals
Investing in the future of
Investing in the future of
Accelerating the development of new drug development technologies and therapeutics to unlock ground-breaking biopharmaceuticals
We have built and maintain a discovery-to-commercialisation pathway through partnering with world-class biomedicine, technology, pharmaceutical and investment organisations.
Investing in a rapidly growing, emergent biopharmaceutical market that requires new technologies, manufacturing and drug discovery pathways to unlock break-through therapeutics.
Many debilitating disorders are poorly served by current drug therapies.Novel plant-based therapeutics are poised to offer breakthrough therapies for these debilitating conditions.To realize the full potential of these medicines we invest in technologies that unlock their safe production and clinical application.